Senior insider sale
VP, Corp Controller and CAO at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.42M
67.11K shares
What this filing means
CALVIN SANDRA plans to sell 67.11K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/4/2025ACC: 0001950047-25-008434
Officer· VP, Corp Controller and CAO
Since Sep 2021
67.11K
Shares to sell
$2.42M
Approx. market value
67.11K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months8
Stock Option Exercise
Cash
11/4/2025
61.25KRestricted Stock
Not Applicable
1/31/2024
1.07KRestricted Stock
Not Applicable
1/31/2023
924.00Restricted Stock
Not Applicable
9/10/2022
651.00Restricted Stock
Not Applicable
1/31/2022
1.08KRestricted Stock
Not Applicable
9/10/2021
651.00Restricted Stock
Not Applicable
3/5/2021
259.00Restricted Stock
Not Applicable
1/31/2021
1.23KTotal acquired67.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/4/2025 | Stock Option Exercise Cash | 61.25K | — |
1/31/2024 | Restricted Stock Not Applicable | 1.07K | — |
1/31/2023 | Restricted Stock Not Applicable | 924.00 | — |
9/10/2022 | Restricted Stock Not Applicable | 651.00 | — |
1/31/2022 | Restricted Stock Not Applicable | 1.08K | — |
9/10/2021 | Restricted Stock Not Applicable | 651.00 | — |
3/5/2021 | Restricted Stock Not Applicable | 259.00 | — |
1/31/2021 | Restricted Stock Not Applicable | 1.23K | — |
| Total | 67.11K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
67.11K
Market value
$2.42M
11/4/2025
Total
Units
67.11K
Value
$2.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/4/2025 | 67.11K | $2.42M | NASDAQ | Planned |
| Total | 67.11K | $2.42M | ||